Hikma Pharmaceuticals (HKMPF) Revenue Analysis | Historical Sales Growth & Trends - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Hikma Pharmaceuticals

    PNK: HKMPF · Real-Time Price · USD
    26.93
    0.73 (2.80%)
    At close: May 07, 2025, 12:33 PM

    Hikma Pharmaceuticals Revenue

    Hikma Pharmaceuticals reported an annual revenue of $3.13B, reflecting a 8.77% growth. For the quarter ending December 31, 2024, Hikma Pharmaceuticals generated $1.56B in revenue.
    Revenue (ttm)
    3.13B
    Revenue Growth
    8.77%
    Price / Sales Ratio
    1.71
    Revenue / Employee
    329.16K
    Employees
    9,500
    Market Cap
    5.94B

    Revenue Chart

    Revenue History

    Fiscal Year End Revenue % Change
    Dec 31, 2024 3.13B +8.77%
    Dec 31, 2023 2.88B +14.22%
    Dec 31, 2022 2.52B -1.41%
    Dec 31, 2021 2.55B +9.06%
    Dec 31, 2020 2.34B n/a
    Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

    Add to Watchlist